Introductory Chapter by Haim Tal
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
 Introductory Chapter 
Haim Tal  
Department of Periodontology and Implantology 
Tel Aviv University     
Israel 
 
The fields of medicine and dentistry continue to develop in an ever-changing environment, 
with day-to-day innovations and discoveries. Among the many procedures that have to be 
implemented in the course of medical and dental therapy, guided bone repair and 
regeneration present vast challenges to the science, art and practice of reconstituting the 
shape and function of damaged skeletal structures.  
Bone is a specialized connective tissue that is characterized mainly by its mineralized 
organic matrix. The bone matrix is composed of collagenous and non-collagenous proteins. 
Within this matrix, calcium and phosphate ions are laid down, ultimately to form 
hydroxyapatite.  In most parts of the skeleton, bone formation occurs during embryogenesis,  
by the initial deposition of cartilaginous templates that are subsequently replaced by bone, a 
process referred to as endochondral bone formation.  In the  cranial vault, in the diaphysis of 
long bones,  and in the alveolar processes of the maxilla and of the mandible,  bone is 
primarily formed within fibrous connective tissue; this is termed intramembranous bone 
formation.  
Mature bones are made up of mineralized tissue and bone marrow. The mineralized 
compartment comprises an outer smooth, compact portion, the cortical bone, and an inner 
spongy part, the trabecular bone, in the proportion, by weight, of about 80% to 20%. The 
cellular component of the mineralized bone tissue, including osteoblasts, osteocytes and 
osteoclasts, is located within and upon the cortical and the trabecular bone. This 
composition and structure of bone allows it to resist load, to protect vulnerable organs, such 
as the central nervous system, and to support functional organs, like the teeth.  
As bone is a specialized connective tissue, osteoblasts rather than fibroblasts are the cells 
primarily responsible for its formation. They are located on bone surfaces, where they 
actively deposit  organic bone matrix and control its mineralization. Osteoblasts are the 
direct descendants of osteoprogenitor cells (Kneser et al., 2006; Buckwalter & Hunziker, 
1996; Heinegard & Oldberg, 1989), and they differentiate  either into bone lining cells or into 
osteocytes. Among other activities, osteocytes participate in the regulation of blood-calcium 
homeostasis and in signalling mechanical loading to other cells within the bone. Since 
osteoblasts are fully differentiated stable cells that lack the ability either to migrate or to 
proliferate, new bone formation is  entirely dependent on the presence of osteoprogenitors, 
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which are undifferentiated mesenchymal cells that can migrate to target sites, proliferate 
and differentiate into osteoblasts.  
It has been suggested that osteoprogenitor cells may be  designated as determined  or as 
inducible osteogenic precursor cells (Friedenstein 1973). The determined osteoprogenitor cells are 
located in the bone marrow, in the endosteum and in the periosteum, and they possess the 
capacity to proliferate and to differentiate into osteoblasts. The inducible osteogenic 
precursor cells (e.g. myoblasts or adipocytes), present in other organs and tissues, may 
differentiate into bone-forming cells when exposed to specific stimuli. The main source of 
osteoprogenitor cells is considered to be the pericyte, a stellate perivascular cell.  
The differentiation of osteoblasts from osteoprogenitor cells is dependent upon the release 
of, or the presence of factors that induce or promote bone growth, among them bone growth 
factors and bone growth proteins, as well as insulin-like growth factor, platelet-derived 
growth factor, and fibroblast growth factor.   
Bone formation and remodelling are consistently associated with bone resorption that is 
initiated and maintained by osteoclasts, which are multinucleated cells originating from 
haematopoietic precursor cells. The processes of modelling and remodelling of bone start 
shortly after bone formation, by resorption and apposition of new mineralized tissue 
resulting in changes in bone architecture and morphology. It is believed that changes 
brought about by bone modelling are induced by functional demands, such as muscle 
tension and external loads, while remodelling  occurs within the bone as an ongoing 
maintenance process.  
Experimental observations show that primary (woven) bone that appears to be more 
amorphous and has a low load-bearing capacity is the first to be formed in areas of bone 
regeneration. Woven bone is gradually replaced by lamellar bone with a structure that is 
more resistant to stress in general, and to functional loading in particular.  
Bone is one of a few tissues that possess spontaneous regenerative capacity; but 
spontaneous regeneration is limited, and falls far short of the ideal ultimate goal of 
therapeutic reconstruction, which is complete restoration of tissues or organs that have been 
damaged or removed, to their original normal structure, architecture, size and function.  
In the oral cavity, for example, the periodontal attachment apparatus is an organ that 
comprises alveolar bone, periodontal ligament and cementum. If the periodontal attachment 
apparatus is disrupted by inflammatory disease such as periodontitis, or by trauma, or by 
surgical damage, spontaneous healing is achieved mainly by repair, i.e., fibrous tissue 
replaces the lost tissues (Le et al. 2005). The capacity of alveolar bone to regenerate has been 
shown to improve significantly in the presence of growth factors, which are natural 
biological mediators that significantly increase cellular chemo-attraction, proliferation and 
differentiation by regulating essential cellular events (Giannobile 1996). Once growth factors 
bind to surface receptors of specific target cells, they induce the activation of genes that 
change cellular activity and phenotype (Anusaksathien & Giannobile 2002; Schilephake 
2002; Ripamonti et al. 2005).  
This book is divided into three sections: chapters 1-5 deal mainly with regenerative tissue 
engineering, chapters 6-10 with different techniques of enhancing and supporting bone 
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regeneration, and chapters 11-14 concentrate on biotechnology, and on recent advances and 
new approaches in developing biomaterials for bone regeneration. 
Regenerative tissue engineering (RTE) may be defined as a process of combining living cells 
with biocompatible scaffolds to generate a biological substitute capable of sustaining itself 
and of integrating with functional native tissue (Chapter 1). RTE addresses the discrepancy 
between available transplantable donor tissues and the anatomical need.  
Optimized methods have improved the function and maturation of engineered cellular 
constructs to produce new ones with clinically useful, near-native tissue properties. 
Following any bone injury, a healing cascade is triggered to restore the tissue’s original 
state. This reaction occurs in the three phases of inflammation, repair, and remodelling. 
Initially, the inflammatory phase follows the formation of a blood clot arising from blood 
flowing and cells migrating into the site of injury from the  borders of the injury. These cells 
include fibroblasts and inflammatory cells, such as macrophages, monocytes, lymphocytes, 
etc., which, together with ingrowing blood vessels that are a source of pericytes, promote 
new formation of collagen fibers and osteoid, forming a soft callus. This process starts 
within hours to a few days after bone injury and continues for about 4-8 weeks, while 
ossification of the callus and the formation of unorganized woven bone may  take an 
additional 2-4 months. This progression of healing events establishes a basis for formulation 
of the principles of guided bone regeneration and distraction osteogenesis (Chapters 6–9).  
The restructuring of woven bone is responsive to muscular activity and to mechanical 
stresses (Kneser et al. 2006). In the dental environment, for instance, restructuring of bone is 
observed around teeth and dental implants which transfer functional and occlusal forces to 
their anchoring bone.  
The range over which healing, followed by spontaneous regeneration of bone may occur is, 
however, of limited potential. If the zone of damage exceeds a certain critical size, a bone 
defect may not self-repair, in which case guided bone regeneration using tissue barriers, 
autologous bone grafts, allografts, xenografts or alloplasts may provide a partial solution 
(Chapters 11-14). The following terms are defined for the sake of clarity:  
 Autografts - human bone is harvested from the recipient of the graft himself or herself. 
This is currently considered by many as being the gold standard for bone grafting.  
 Allografts - human bone for grafting harvested from donors usually unrelated to the 
recipient. Such grafts do not have the recipient-compatible immunogenic properties of 
autografts, thus increasing the risk of rejection (Mankin et al., 2005). Allografts are 
generally osteoconductive, although some are osteoinductive, depending somewhat 
upon the source of the bone and the technique of preparation.  
 Xenografts - deproteinized bone grafts prepared from species other than human that 
contain only the hydroxyapatite matrix of bone. Xenografts are osteoconductive. 
 Alloplasts - synthetic grafts made of biocompatible and/or bioactive materials, such as 
ceramics, bioglasses or calcium sulphate. Some alloplastic materials have the potential 
to be used as carriers of growth factors, thereby improving their osteoconductive and 
osteoinductive properties.     
The potential of regenerative tissue engineering (RTE)  has attracted much interest in the 
field of bone research. Current studies on RTE focus mainly on stem cells. The human body 
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has many different types of cells, each specialized for a distinct rôle. The cells are committed 
to specific lineages and functions, for example, cardiomyocytes in the heart, chondrocytes in 
cartilage, and osteoblasts in bone. Cells are assessed for their possible utility for tissue 
engineering, mainly by their rate of proliferation and by their potential for differentiation, 
both of which depend upon the speed at which the individual cells divide as well as on the 
cell line’s capability of developing into specific lineages, in our case, an osteogenic lineage. 
For the engineered tissue to mirror the native tissue, it is essential for the  cells to expand at 
a specific rate and to differentiate towards the desired lineage.  
Stem cells are multipotent, not lineage-specific, with the potential to differentiate into many 
kinds of specialized daughter cells. Adult stem cells can be harvested from various tissues of 
the body and can then be cultured in vitro, where they can be directed to provide a 
potentially  unlimited supply of tissue. Stem cell-based bone tissue engineering is founded 
upon the potential of multipotent postnatal stem cells to participate in the regenerative 
healing of bone defects. Postnatal stem cells can be isolated from bone marrow, from 
adipose tissue, from muscle, from dental pulp tissue, from oral mucosa and from umbilical 
cord (Zuk et al., 2001; Miura et al., 2003; Schugar et al., 2009). It is noteworthy that in spite of 
the fact that embryonic stem cells are considered to be the gold standard in RTE , postnatal 
bone marrow-derived mesenchymal stem cells are the most researched and the most 
frequently used. 
Clinically, most efforts to increase bone volume have focused on procedures that exploit 
spontaneous bone regeneration. The introduction of dental implant therapy, and the well 
established need for adequate bone volume at the implant site, in order to foster a 
favourable long-term prognosis for dental implants (Lekholm 1986) have dramatically 
increased interest in the development of implant sites.  
Four approaches to the augmentation of bone volume have been described: a. osteoinduction, 
using appropriate growth factors (Urist 1965 ; Reddi 1981); b. osteoconduction, using grafting 
materials that serve as scaffolds for new bone growth (Buch et al. 1986; Reddi et al. 1987); c. 
distraction osteogenesis, by which bone growth is induced between the fragments at a 
surgically created bone fracture when the fragments are pulled apart in a slow, controlled 
manner. (Ilizarov 1989a,b); d. guided bone regeneration, which allows selective growth of bone 
tissue into a space maintained by tissue barriers (Dahlin et al. 1988, 1991a,b; Kostopoulos & 
Karring 1994; Nyman & Lang 1994). The purpose of all these procedures is to deal with the 
problem of localized lack of bone volume resulting from congenital, post-traumatic, 
postsurgical or pathological defects in various parts of the skeleton (Chapters 6-10).  
Guided-tissue regeneration (GTR) was introduced into dental clinical practice soon after it 
became understood that the alveolar bone and the periodontal ligament can be sources of  
progenitor cells  for the regenerative repair of adjacent periodontal lesions (Melcher 1970, 
1976). Karring et al. (1980) and Nyman et al. (1980) formulated the basic principles of GTR 
over three decades ago. These are as follows: under certain conditions, cells that originate 
from a tissue adjacent to a delimited space are able to grow into that space and to form new 
tissue identical to their tissue of origin. In order to allow exclusive migration into, and 
population of such a space by a specific tissue, cells  of that tissue must be given preferential 
access to the space. This is achieved by preventing access of cells from neighbouring 
dissimilar tissues by means of tissue barriers, commonly referred to as membranes.  
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For detailed discussion of the rationale and techniques of contemporary GBR procedures 
and the biotechnology associated with resorbable collagen bio-barriers, the reader is referred 
to Chapters 6 and 7. There is a wide variety of available resorbable and non-resorbable 
tissue barrier materials, including polytetrafluoroethylene (PTFE), expanded PTFE (e-PTFE), 
polyglactin 910, polylactic acid, polyglycolic acid, polyorthoester, polyurethane, 
polyhydroxybutyrate, calcium sulfate, freeze-dried fascia lata and freeze-dried dura mater 
allografts, titanium micro-mesh, and titanium foil.  
Collagen membranes are generally to be preferred to other barrier materials because they 
possess all the essential properties required in a bio-barrier, including biocompatibility, cell 
occlusiveness, integration into the host tissues, space-making  capacity,  and also clinical 
manageability and ease of application.  
To secure the space necessary for bone regeneration in GBR procedures, tissue barrier 
membranes need to be supported, or they will collapse owing to peripheral pressure, thus 
possibly reducing or completely eliminating the space that had been designated for 
potential bone growth and regeneration. Although membrane-stiffeners, or a wide range of 
membrane-supporting materials have been claimed successfully to fulfill the necessary 
requirements for membrane support, there is an ongoing search for new materials, both 
osseoinductive and osseoconductive, to be placed under the membrane (Chapters 11-14). 
The current consensus is that the optimal osteoconductive membrane-supporting material is 
one that interferes least with the spontaneous bone growth replacing the submembranous 
clot of blood. Taking this a step further, however, it may well be that with advances in 
engineered bone regeneration, future materials will promote bone growth, perhaps to the 
extent that tissue barriers may become unnecessary.  
The main limitation of  current guided bone regeneration procedures is that reliance is 
placed upon bone’s spontaneous regenerative capacity, which suffices only for defects of 
limited size. Furthermore, the problem of stabilization of the volume of regenerated bone is 
a major limiting factor in bony defects of this nature, especially when lateral and, even more 
so, vertical bone loss is to be treated. Other measures, such as block grafts or distraction 
osteogenesis, may be more suitable for those cases.  
The effectiveness of bone grafts depends on their osteoinductivity and osteoconductivity as 
well as on their biomechanical properties (Khan et al., 2005). Synthetic block grafts have 
recently been added to the range of available allografts: these grafts provide sizable, stable 
scaffolds that encourage new bone formation originating from any bone that is in direct 
contact with the graft material (Chapter 10). Therefore, while autologous block grafts still 
remain the gold standard, allograft and alloplast blocks reduce morbidity by obviating the 
need for harvesting bone blocks from the patient's iliac crest, fibula, ribs, calvaria or 
mandible (Burchardt, 1983).  
Distraction osteogenesis (DO) may offer a viable alternative when size or volume of a bone 
defect exceeds the capacity of grafting successfully to replace the missing tissue. DO is a 
surgical technique by which, through the appropriate application of traction to the bone, the 
intrinsic capacity of bone to regenerate is directed towards lengthening or altogether 
replacing segments of bone. DO allows the spontaneous de novo formation of native bone 
without bone grafts. It may be considered a type of in vivo bone tissue engineering and may 
be superior to other techniques in certain cases. The current status, future developments and 
applications of DO are discussed in Chapters 8 and 9.  
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A number of extrinsic, local or systemic factors may affect bone mass, volume, structure and 
density, thereby influencing skeletal function. Among these, osteopenia, osteoporosis, 
diabetes mellitus, smoking and periodontal disease are frequently mentioned in  the context 
of the jaws. This subject is not discussed separately in this book since data on the influence 
of those conditions on bone regeneration and on osseointegration in the setting of oral and 
orthopaedic implants are limited, neither is there any agreement on whether or not they 
should be  regarded as contraindications for implant placement (Shernoff et al., 1994; Farzad 
et al., 2002).  
In view of the increasing clinical application of bone regenerative procedures to dental 
implant site development, the relationship between such procedures and general health 
conditions has attracted considerable interest. However, no conclusive data are available 
with respect to bone augmentation procedures in patients suffering from those systemic 
diseases or conditions referred to above, including smoking, or in those with poor 
compliance in bacterial plaque control, any of which can have the effect of impairing tissue 
healing.  
On the other hand, in patients who have lost their teeth owing to periodontal disease, 
implant procedures had greater rates of failure and more complications, than implant 
procedures in patients in whom periodontal disease had not been the primary reason for 
tooth loss (Mengel et al., 2001; Hardt et al., 2002; Karoussis et al., 2003; Wennstrom et al., 
2004).  
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